By Shania Kennedy
January 18, 2024 – A research team from Johns Hopkins Children’s Center has found that an autonomous artificial intelligence (AI) tool to screen youth populations for diabetic eye disease (DED) can also increase…
Continue Reading
The ADA Scientific Sessions showcased advancements in diabetes care, including an AI tool for predicting diabetic retinopathy progression and a glucose sensing and delivery device for Type 1 diabetes. The AI tool improves risk…
Continue Reading
Last year, Eyenuk CEO Kaushal Solanki told MedCity News his company is on a mission to “screen every eye in the world” by leveraging its AI-powered disease detection technologies.
Eyenuk still has a lot of…
Aegis Ventures and Northwell Holdings, the investment arm of the New York-based health system, on Tuesday launched Optain, a company that aims to use AI-backed retinal imaging to catch early signs of disease. The…
Continue Reading
What You Should Know:Today Ascertain, the partnership between Aegis Ventures and Northwell Holdings, announced a $12M seed funding round to launch its first company, Optain, an artificial intelligence (AI) company leveraging retinal imaging to…
Continue Reading
